A Leading Outsourcing Partner to the pharmaceutical industry
Welcome to Dishman Carbogen Amcis Ltd!
We are a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services. The Dishman Group continually invests in the pharmaceutical industry, ensuring our businesses can provide pharmaceutical customers with high-value, high-quality products and services today and in the future. Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. We strongly believe that our business is successful only when our customers are successful.
Our Mission
The mission of Dishman Carbogen Amcis Ltd and its fundamental purpose is to offer support and assistance to people across the world suffering from illness and disease, striving to ensure that this is completed efficiently, comprehensively, and effectively.
Latest News
-
News
Dishman Carbogen Amcis Ltd announces successful USFDA inspection of its Naroda facility
AHMEDABAD, India (June 13, 2025) - Dishman Carbogen Amcis Ltd’ Naroda manufacturing facility went through an inspection by the USFDA between 9th to 12th June, 2025, which was concluded without any observations, confirming that no concerns were identified.
Paolo Armanino, COO of Dishman Carbogen Amcis Ltd, spoke about the company's achievement regarding the recent USFDA inspection:
-
News
Dishman Carbogen Amcis Ltd receives 'Choose France - Best Indian Investment in France' award from the Indo French Chamber of Commerce and Industry (IFFCI)
NEW DELHI, India, (April 18, 2024) – Dishman Carbogen Amcis Ltd received the Choose France-Best Indian Investment in France award by the Indo French Chamber of Commerce & Industry in partnership with Business France India, at the sixth flagship event of the Indo-French Business Awards (IFBA) and Grand Prix VIE, in New Delhi. His Excellency Mr. Thierry Mathou, Ambassador of France presented the award which recognises Dishman’s investment in a new...
-
News
Dishman Carbogen Amcis Ltd awarded Certification of GMP Compliance by Japan’s Health Authority
Gujarat, India - After a successful on-site inspection, Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), receives the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) certification.
DCAL’s drug substances manufacturing facility located in Bavla, underwent an inspection by the Japanese Health Authority. We are glad to announce that the inspection ended satisfactorily, and no major or critical observations...
-
News
USFDA GRANTS EIR TO CLOSE INSPECTION AT DISHMAN'S BAVLA MANUFACTURING FACILITY
Gujarat, INDIA (March 2024) – Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), a pharmaceutical API manufacturing and drug development company receives the USFDA certification after a successful inspection of its manufacturing facility in Bavla.
The inspection conducted by the United States Food and Drug Administration (US FDA) at Dishman Carbogen Amcis Ltd's facility in Bavla, Ahmedabad, which was scheduled from March 4 to March 8, 2024, was successfully completed...
-
News
Dishman Carbogen Amcis Ltd granted CEP by EDQM and EUDRA GMP Certification by the Italian Medicines Agency
Gujarat, INDIA (January 2024) – Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), a pharmaceutical API manufacturing and drug development company receives the CEP certification by the EDQM and the EUDRA GMP by the Italian...
-
News
Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19
Ahmedabad, India (December 9th, 2021) — Dishman Carbogen Amcis Ltd, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new Clinical Research Study which shows that oral 25-Hydroxyvitamin D3 (Calcifediol) was able to correct vitamin D deficiency/insufficiency in patients with COVID-19 and that it resulted in improved immune function by increasing blood...
Upcoming events
-
CPhI Worldwide 2025
Events
CPhI Worldwide in Frankfurt
CPhI Worldwide will return to Frankfurt from 28 - 30 October 2025!
Booth #6.0D6
Meet our team from Dishman Carbogen Amcis Ltd in Frankfurt! Join our global network of pharma professionals and connect with thousands of industry leaders. Expand your network with endless opportunities to learn, innovate, and collaborate.Book your meeting with us! CPHI facilitates opportunities for you to grow your business and develop meaningful connections at the heart of pharma.Visit our Contact us page.
OTHER EVENTS
CONTACT US TODAY OR DOWNLOAD
OUR COMPANY PROFILE BROCHURE
FOR FURTHER INFORMATIONSUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES
CONTACT US TODAY OR DOWNLOAD
OUR COMPANY PROFILE BROCHURE
FOR FURTHER INFORMATION
“Dishman Group” is not a separate legal entity but nomenclature used in generality for Dishman Carbogen Amcis Ltd, the flagship Company, and its Indian and foreign subsidiaries, joint ventures and associate companies across the globe. All these entities are individual and separate by the law.
